Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol vs Aspirin for Prevention of Recurrent Cerebral Infarction (CSPS 2)
NCT00234065Phase 4Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- Dec 2003
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of cilostazol in cerebral infarction, sponsored by Otsuka Pharmaceutical Co., Ltd.. Started Dec 2003; status: completed.
02
Drugs
cilostazol
03
Conditions
cerebral infarction
Beyond the preview
Go deeper on NCT00234065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00234065.